獨家:Cambridge Mobile Telematics 從 TPG、Allianz 籌得 3.5 億美元,致力提升駕駛安全

(SeaPRwire) -   Cambridge Mobile Telematics 已悄然成為「讓駕駛更安全」競賽中,你可能從未聽說過的最重要企業之一——而現在,全球幾大保險業者正加倍押注於它。據獨家獲悉,這家總部位於麻薩諸塞州劍橋市的公司,已獲得由 TPG 的 Rise Funds 和 Allianz X 領投的 3.5 億美元戰略投資,現有投資方 State Farm 也參與了這筆全次級交易。 CMT 開發人工智慧驅動的車聯網(telematics)軟體,將日常設備——智慧型手機、汽車感測器、行車記錄器及其他連網硬體——轉化為道路上的即時風險偵測器。其 DriveWell Fusion 平台匯入數百萬台設備的感測器資料,並結合情境資訊,建立人們實際駕駛行為的統一視角,涵蓋急剎車、超速到手機分心等行為。接著,保險業者、汽車製造商及公共機構運用這些洞見進行風險定價、偵測車禍,並引導駕駛養成更安全的習慣。  根據 Frost & Sullivan 及該公司資料,截至目前,CMT 技術支援的計畫已協助避免超過 10 萬起車禍及 5.4 萬起嚴重傷害,並支援超過 140 項安全駕駛倡議,觸及 25 個國家逾 5,500 萬名駕駛。TPG 指出,該公司目前已服務美國前 25 大汽車保險業者中幾乎所有業者。 背後的商業規模不容小覷。第三方估計,CMT 的私人估值已超過 10 億美元大關。這筆新交易之前,軟銀(SoftBank)的愿景基金(Vision Fund)曾於 2018 年投資 5 億美元,當時是麻薩諸塞州規模最大的科技融資案之一。 CMT 共同創辦人兼執行長 Powers 以簡單方式解釋這些資金的用途。「若從移動出行領域來看,我們是一家人工智慧行動感測公司,」他表示。「多數車輛都會發出信號,可能來自駕駛的手機,也可能來自車輛本身,但我們測量信號,而非追蹤事物。我們測量信號。」除了保險領域,CMT 的公共部門部門也與城市及交通機構合作,了解人們的移動模式、重新設計危險路段,並為老舊基礎建設因應更自動化的駕駛做好準備。​​ 這筆對 CMT 的戰略投資備受矚目,不僅因其規模,更因其「非典型」之處。Powers 表示:「這筆資金完全不是初級資本(primary capital),而是全次級交易(secondary transactions),意味這筆交易不會造成股權稀釋——零稀釋。」這筆新資金的用途,是透過收購舊投資人股權,並為長期員工及股東提供流動性,進一步推動業務創新。「我們已深耕 16 年,」他表示。「我們持續創造現金流,並一路為相關人士提供流動性。」​  TPG Rise Fund 合夥人 Akash Pradhan 表示,該機構投資 CMT 源於其相信這家車聯網公司將成為道路安全的「關鍵任務」基礎設施,能將超過 75 petabytes 的資料轉化為基礎人工智慧,既拯救生命,也降低保費。 對 Allianz X 而言,這筆交易兼顧戰略與報酬。該部門是安聯(Allianz)的戰略投資分支,而非傳統的 GP/LP 基金,隸屬於 2025 年總保費約 2,171 億美元、營運獲利 202 億美元、服務全球約 9,700 萬名客戶的集團。「Allianz X 不是基金,因此我們沒有 GP 架構,」執行長 Dr. Nazim Cetin 表示。「我們是安聯的戰略投資單位。」 近年來,安聯積極建構數位理賠系統,收購 ControlExpert、Innovation Group 及 GT Motive 等公司,自動化從照片損害評估到將車輛導向適當維修廠等流程。CMT 的車聯網技術將位於該系統的上游,協助從源頭預防事故,並在事故發生時為理賠流程提供更豐富的資料。  Cetin 強調,Allianz X 仍以傳統創業投資者的方式評估這筆交易。「若一家公司單獨來看無法提供我們預期的風險報酬概況,我們不會投資,」他表示。「在這筆交易中,我們的預期與任何創業投資者對此類投資的預期一致。」但不同於傳統基金,安聯的資本「沒有到期日」,使其更有耐心實現財務報酬及營運效益,例如降低理賠頻率及為保戶提供更客製化的定價。​​ 這筆投資背後也有強大的財務實力支撐。TPG 透過多項策略管理超過 3,000 億美元資產,並將其 Rise 影響力平台打造成自稱全球最大的專注影響力投資的品牌,管理資產約 310 億美元。Allianz X 隸屬於歐洲及全球最大汽車保險業者之一,而 CMT 早期投資方 State Farm 則運營美國最廣泛使用的車聯網計畫之一「Drive Safe & Save」,涵蓋超過 9,000 萬份保單及帳戶。對 Powers 而言,這樣的網絡不僅代表資金,更關乎分銷能力。「由於我們長期獲利,且真正掌握自身命運,我們得以選擇合作夥伴時更具選擇性,」他表示。但最終,Powers 表示,他對 CMT 的願景很簡單:協助讓世界比他初見時更美好。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Games Global and Just For The Win® carry on the ghostly adventure in Dark Waters III Power Combo: The Cursed Voyage™

(AsiaGameHub) -   Games Global, in collaboration with its exclusive studio partner Just For The Win®, has revealed Dark Waters III Power Combo: The Cursed Voyage, the newest entry in the well-regarded Dark Waters series, delving further into a supernatural maritime adventure. Building on the success of its earlier installments, the sequel develops the existing Power Combo framework with a design rich in features and a gameplay experience that is layered in depth. Set within a mysterious pirate-themed world, the 6×4, 4,096 ways game introduces the Sail into Riches progression meter, where a six-stage journey unlocks feature upgrades and improved gameplay as players move forward. Central to the game is the Cash Collect feature, where Money Symbols ranging from 5x to 5,000x can land across the reels and are awarded when a Collect symbol appears. Free Spins are activated by landing Bonus Tokens, revealing the Power Combo mechanic where Giant Reels, Stack Collect, and Golden Reels can combine. Each feature upgrades across four levels, expanding the reels to a 6×8 grid that offers up to 262,144 ways to win, boosting Collect potential, and filling reels with Money Symbols to enhance winnings. Extra depth is provided through the Diamond Menu, which includes features such as Bonus Hunt, Coin Burst, Crew’s Choice, and Captain’s Choice, each offering unique ways to access or enhance bonus features. Dark Waters III Power Combo: The Cursed Voyage delivers a compelling continuation of the franchise, merging evolving mechanics with the series’ well-known strong thematic identity. Edward Eklund, Account Manager at Just For The Win® Studios, said: “With Dark Waters III Power Combo: The Cursed Voyage, we sought to create a sense of progression that players can truly feel, where every spin contributes to something more substantial. “Combining that journey with the adaptability of the Power Combo mechanic allowed us to craft a game that continuously evolves and keeps players engaged.” David Reynolds, Director of Games Strategy and Partner Management at Games Global, said: “This latest installment showcases how Just For The Win® continues to refine and elevate a proven concept, building on the strong success of the Dark Waters series to date. “Dark Waters III Power Combo: The Cursed Voyage stands out for its ability to keep gameplay fresh while remaining immediately accessible. It is a fantastic addition that strengthens what has already been a hugely popular trilogy.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

首席執行官如何應對有史以來最大的能源衝擊

今日《CEO Daily》重點: Diane Brady報導能源業執行長對伊朗戰爭的反應。 焦點新聞: Mark Zuckerberg的人工智慧助手所引發的連鎖效應。 市場動態: 因伊朗戰爭籠罩不確定性,全球市場表現參差。 其他: 所有新聞與閒聊話題來自。 (SeaPRwire) -   早安。 來自全球的能源業領袖現正齊聚休士頓,參加由S&P Global主辦的年度CERAWeek會議。當然,會議的一大主題是霍爾木茲海峽的實際封鎖,這已切斷全球20%的原油和液化天然氣供應,造成有史以來最嚴重的全球能源供應衝擊。 根據’s能源編輯Jordan Blum從休士頓發回的報導,雪佛龍(Chevron)執行長Mike Wirth認為油價可能過低。Wirth向與會者表示:「霍爾木茲海峽封鎖帶來的實際物質影響正透過系統在全球擴散,我認為市場尚未完全反映這些因素。」 事實上,受創嚴重的亞洲國家正透過推動遠距工作、暫停學校課業等方式儲備和節約能源。這場戰爭也癱瘓了氦氣和肥料供應,同時打擊晶片製造商和農民。(周一傳出可能展開和平談判的消息後,股市甚至比特幣均出現反彈。) 由於衝突,多名中東領袖本周未親臨休士頓:沙特阿美(Saudi Aramco)執行長Amin Nasser已退出,其他人則以視訊方式參與。科威特國營石油公司(Kuwait Petroleum Corporation, KPC)執行長Sheikh Nawaf Al-Sabah則預定今日以視訊方式參與。阿聯酋能源與先進科技部長兼阿布扎比國家石油公司(Abu Dhabi National Oil Co, Adnoc)負責人Ahmed Al Jaber昨日以視訊方式發表演說,他表示:「將霍爾木茲海峽武器化並非針對單一國家的侵略行為,而是對所有國家的經濟恐怖主義。」 儘管美國企業執行長在能源供應方面面臨的衝擊可能較不直接,但他們仍需應對其他後果。我上周在紐約的晚宴上與多位執行長交談,也與幾位前往CERAWeek的高管討論過此事。部分人士默默呼應政治領袖的看法,認為阻止伊朗是實現區域繁榮的必要之舉;另一些人則對這場非由他們發起的戰爭給企業帶來的損失表示憤怒。所有人都在應對後果,並意識到即使達成和平協議,影響仍可能長期持續。正如一位人士所說:「這場戰爭已對敵我雙方造成永久性損害。」 務必追蹤Jordan對CERAWeek和中東最新消息的報導。透過Diane Brady聯絡CEO Daily,郵件:diane.brady@.com本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

USPA Global and ESPN Expand Relationship with Chris Fowler for 2026 High-Goal Polo Championships

West Palm Beach, FL, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - Global Polo, the entertainment subsidiary of USPA Global, continues its historic relationship with ESPN to showcase the sport of polo, which has expanded its reach to millions of households worldwide. The landmark relationship includes legendary ESPN commentator Chris Fowler hosting the USPA Gold Cup® Final on Mar. 29 for the first time, and the U.S. Open Polo Championship® Final on Apr. 26 for the second year, at the USPA National Polo Center in Palm Beach County, Florida, alongside veteran broadcasters Kenny Rice and Polo Hall-of-Famer Adam Snow.Legendary ESPN Commentator, Chris Fowler, at the USPA National Polo Center in Palm Beach County, FloridaPhoto Credit: Alex Pacheco"I've had the privilege of covering some of the most iconic events in sports, and what continues to draw me back to the sport of polo is the unique partnership between the polo player and polo pony, as well as the speed and intensity of competition at the highest level," said Fowler. "Hosting both the USPA Gold Cup and the U.S. Open Polo Championship allows me to share the energy and uniqueness of this beautiful sport with a broader ESPN audience.""There's nothing quite like seeing these world-class athletes and their equine partners compete in such a fast-paced, strategic game," Fowler added.The USPA Gold Cup, first played in 1974, is the second most important tournament in American polo, right next to the U.S. Open Polo Championship, which was first played in 1904. This year's competition will feature 10 elite teams competing at the highest level of the sport from March 4 - 29. The prestigious U.S. Open Polo Championship, played April 1 - 26, is widely recognized as a showcase for many of the world's top players and equine athletes and remains one of the most prestigious polo tournaments globally. Both tournaments have been played back-to-back since they arrived in Palm Beach County, Florida, in 2004. These highly rated polo competitions take place on the U.S. Polo Assn. Stadium Field One at the USPA National Polo Center (NPC) in Wellington, Florida.Coverage of the USPA Gold Cup final in early April, followed by the U.S. Open Polo Championship final match in May, will be available on multiple ESPN platforms, including ESPN2. Check your local listings for specific airtimes."Our long-term relationship with ESPN continues to elevate the sport of polo, the U.S. Polo Assn. brand, and the global momentum behind it," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar global sport brand, U.S. Polo Assn. "Chris Fowler's return and expanded presence hosting both the USPA Gold Cup and the U.S. Open Polo Championship further strengthens the momentum and visibility of these world-class tournaments to a global audience.""Supported by ESPN, the sport of polo continues to garner interest from fans around the world," added Prince.Beyond live game coverage, ESPN platforms also feature new episodes of the two-time award-winning show, Breakaway: Presented by U.S. Polo Assn. produced by Global Polo. Viewers can follow exclusive behind-the-scenes coverage, player features, and championship highlights on Global Polo's YouTube channel, including special coverage tied to the USPA Gold Cup and the U.S. Open Polo Championship broadcasts."The United States Polo Association is delighted to see the continued growth of the sport through our relationship with ESPN," said Stewart Armstrong, Chairman of the United States Polo Association (USPA). "The USPA Gold Cup and the U.S. Open Polo Championship represent the highest level of competition at the USPA National Polo Center for the American season, and the increased visibility provided by ESPN underscores the athleticism, dedication, and tradition that define our sport."For the most up-to-date information and breaking news, sign up for the Polo Insider newsletter at globalpolo.com and visit uspolo.org.About ESPNESPN, the world's leading multiplatform sports entertainment brand, features seven U.S. television networks, the leading sports app, direct-to-consumer ESPN+, leading social and digital platforms, ESPN.com, ESPN Audio, endeavors on every continent around the world, and more.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sportsin India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.About the United States Polo Association® (USPA)The United States Polo Association® is organized and exists for the purposes of promoting the game of polo; coordinating the activities of its member clubs and registered player members; arranging and supervising polo tournaments, competitions, and games; and providing rules, handicaps, and tournament conditions for those events. Its overarching goals are improving the sport and promoting the safety and welfare of its human and equine participants. Founded in 1890, the USPA is the largest voluntary sports organization in North America for the sport of polo. The USPA is currently made up of more than 200 member clubs and over 5,000 registered player members. It annually awards and oversees roughly 50 national tournaments hosted by its member clubs. For more information, please visit uspolo.org.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.954.673.1331 - E-mail: skovalsky@uspagl.comChristine Calcagno - Sr. Publicist, ESPN CommunicationsPhone +001.959.216.8036 - E-mail: christine.b.calcagno@espn.comSOURCE: USPA Global Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

USPA Global 與 ESPN 擴大合作關係,攜手克里斯·福勒(Chris Fowler)共同呈現 2026 年高分級馬球錦標賽

佛羅里達州西棕櫚灘, 2026年3月24日 - (亞太商訊 via SeaPRwire.com) - USPA Global 的娛樂子公司 Global Polo 延續與 ESPN 的歷史性合作關係,持續推廣馬球運動,其影響力已擴及全球數百萬家庭。這項里程碑式的合作包含:傳奇ESPN解說員克里斯·福勒將首度主持3月29日的USPA金盃®決賽,並於4月26日第二度主持美國公開馬球錦標賽®決賽。賽事將於佛羅里達州棕櫚灘縣的USPA國家馬球中心舉行,屆時他將與資深播報員肯尼·萊斯及馬球名人堂成員亞當·斯諾共同主持。Legendary ESPN Commentator, Chris Fowler, at the USPA National Polo Center in Palm Beach County, FloridaPhoto Credit: Alex Pacheco「我有幸報導過體育界許多最具標誌性的賽事,而讓我持續被馬球運動吸引的,正是馬球選手與馬匹之間獨特的夥伴關係,以及頂級賽事中那令人屏息的速度與激烈程度,」福勒表示。「能同時主持美國馬球協會金盃賽與美國公開馬球錦標賽,讓我得以將這項美麗運動的活力與獨特性,分享給更廣大的ESPN觀眾。」「親眼見證這些世界級運動員與他們的馬匹夥伴,在如此節奏明快且講求策略的比賽中競技,是無與倫比的體驗,」福勒補充道。美國馬球協會金盃(USPA Gold Cup)始於1974年,是美國馬球界僅次於美國公開馬球錦標賽(U.S. Open Polo Championship)的第二大賽事,而後者則始於1904年。今年的賽事將於3月4日至29日舉行,屆時將有10支頂尖隊伍在最高水平的競技中一較高下。而備受矚目的美國公開馬球錦標賽將於4月1日至26日舉行,該賽事被公認為眾多世界頂尖球員與馬匹的展示舞台,至今仍是全球最具聲望的馬球賽事之一。自2004年移師佛羅里達州棕櫚灘郡以來,這兩項賽事便一直接連舉行。這些備受矚目的馬球賽事將於佛羅里達州威靈頓的美國馬球協會國家馬球中心(NPC)內,美國馬球協會第一球場舉行。四月初的美國馬球協會金盃(USPA Gold Cup)決賽,以及隨後於五月舉行的美國公開馬球錦標賽(U.S. Open Polo Championship)決賽,都將透過ESPN2等多個ESPN平台進行轉播。具體播出時間請查閱當地節目表。「我們與ESPN的長期合作關係,持續提升馬球運動、U.S. Polo Assn.品牌及其背後的全球影響力,」USPA Global總裁兼執行長J. Michael Prince表示。該公司負責管理市值數十億美元的全球運動品牌U.S. Polo Assn. 「克里斯·福勒(Chris Fowler)的回歸,以及他將同時主持USPA金盃賽與美國公開馬球錦標賽的擴展參與,進一步強化了這些世界級賽事在全球觀眾心中的熱度與能見度。」「在ESPN的支持下,馬球運動持續吸引著全球球迷的關注,」普林斯補充道。除了現場賽事轉播外,ESPN 平台還將播出由 Global Polo 製作、兩度獲獎的節目《Breakaway:U.S. Polo Assn. 呈獻》的新集數。觀眾可透過 Global Polo 的 YouTube 頻道收看獨家幕後花絮、球員專訪及錦標賽精華片段,其中包含與 USPA 金盃賽及美國公開馬球錦標賽轉播相關的特別報導。「美國馬球協會(USPA)很高興看到這項運動透過與ESPN的合作關係持續發展,」美國馬球協會(USPA)主席史都華·阿姆斯壯表示。「USPA金盃賽與美國公開馬球錦標賽代表著美國賽季中,在USPA國家馬球中心舉行的最高水準賽事,而ESPN所提供的更高曝光度,更凸顯了定義我們這項運動的運動精神、奉獻精神與傳統。」欲獲取最新資訊與即時快訊,請至 globalpolo.com 訂閱《Polo Insider》電子報,並造訪 uspolo.org。關於 ESPNESPN 作為全球領先的多平台體育娛樂品牌,旗下擁有七個美國電視頻道、頂尖的體育應用程式、直接面向消費者的 ESPN+ 服務、領先的社交與數位平台、ESPN.com、ESPN Audio,以及遍及全球各大洲的業務據點等。關於 U.S. Polo Assn. 與 USPA GlobalU.S. Polo Assn. 是美國馬球協會(USPA)的官方運動品牌。USPA 成立於 1890 年,是美國規模最大的馬球俱樂部與馬球選手組織。憑藉數十億美元的全球業務規模,以及透過超過 1,200 家 U.S. Polo Assn. 實體門市及數千個其他銷售據點的全球分銷網絡,U.S. Polo Assn. 為全球 190 多個國家的男女及兒童提供服飾、配件與鞋類產品。該品牌贊助全球各大馬球賽事,包括每年於棕櫚灘的 NPC 舉辦的「美國公開馬球錦標賽®」(U.S. Open Polo Championship®),此為美國首屈一指的馬球錦標賽。透過與美國 ESPN、歐洲 TNT 和 Eurosport 以及印度 Star Sports 的歷史性合作協議,由 U.S. Polo Assn. 贊助的多項世界頂級馬球錦標賽現已透過電視轉播,讓全球數百萬體育迷首次得以欣賞這項令人振奮的運動。根據《License Global》的報導,U.S. Polo Assn. 一直與 NFL、PGA 巡迴賽和一級方程式賽車並列為全球頂尖的運動授權商之一。此外,這個受運動啟發的品牌因全球業務拓展及體育內容而屢獲國際獎項肯定。憑藉其作為全球品牌的巨大成功,U.S. Polo Assn. 曾獲《富比世》、《財星》、《現代零售》及《GQ》等媒體報導,並登上雅虎財經與彭博社等全球眾多知名媒體平台。欲了解更多資訊,請造訪 uspoloassnglobal.com 並追蹤 @uspoloassn。USPA Global 是美國馬球協會(USPA)的子公司,負責管理市值數十億美元的運動品牌 U.S. Polo Assn.。USPA Global 同時管理其子公司 Global Polo,該公司是全球馬球運動內容的領導者。欲了解更多資訊,請造訪 globalpolo.com 或 YouTube 上的 Global Polo 頻道。關於美國馬球協會® (USPA)美國馬球協會® 的成立宗旨在於推廣馬球運動;協調其會員俱樂部及註冊球員的活動;籌辦並監督馬球錦標賽、競賽及比賽;並為相關賽事制定規則、讓分制度及賽事條件。其核心目標在於提升這項運動的水平,並促進人類與馬匹參與者的安全與福祉。USPA 成立於 1890 年,是北美地區規模最大的馬球自願性體育組織。USPA 目前擁有超過 200 家會員俱樂部及 5,000 多名註冊球員會員。該協會每年頒發獎項並監督由其會員俱樂部主辦的約 50 場全國性錦標賽。如需更多資訊,請造訪 uspolo.org。如需更多資訊,請聯絡:香農·斯蒂爾森(Shannon Stilson)-體育行銷與媒體副總裁 電話 +001.561.227.6994 - 電子郵件:sstilson@uspagl.com史黛西·科瓦爾斯基(Stacey Kovalsky)-全球公關與傳播副總裁 電話 +001.954.673.1331 - 電子郵件:skovalsky@uspagl.com克里斯汀·卡爾卡尼奧(Christine Calcagno) - ESPN 傳播部資深公關專員 電話 +001.959.216.8036 - 電子郵件:christine.b.calcagno@espn.com消息來源:USPA Global Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Media Troopers Teams with Canadian Gaming Law Firm to Gear Up for Alberta iGaming Launch

(AsiaGameHub) -   Leading digital marketing and customer acquisition firm Media Troopers has revealed it’s preparing to enter Alberta’s soon-to-launch regulated iGaming market through a partnership with Alon Segev, Managing Partner, and Ron Segev, founder of Canadian gaming and betting legal practice Segev LLP. Alberta is set to be Canada’s second province to regulate commercial online gambling, after Ontario did so in 2022. Last May, the province approved the iGaming Alberta Bill, which established a framework for operators to enter the market and created a new iGaming regulatory body—the Alberta iGaming Corporation. As part of its strategic entry into this new sector, Media Troopers has teamed up with Segev, which will advise the company on regulatory strategy, compliance requirements, and market readiness as Alberta finalizes its operational and licensing framework. “Alberta represents one of the most exciting emerging regulated markets in North America,” said Shmulik Segal, CEO of Media Troopers. “Working with Ron Segev and the team at Segev LLP ensures that our expansion into the province will be aligned with the evolving regulatory framework and positioned for long-term success.” Similar to Ontario’s competitive landscape, Media Troopers is committed to supporting licensed operators in Alberta through localized marketing channels, affiliate partnerships, and compliance-focused customer acquisition strategies. “Canada’s iGaming market continues to evolve rapidly,” Segal added. “Our goal is to be fully prepared to support operators entering Alberta from day one.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

ENJOY’s Italian market access achieved as regulated expansion strategy progresses

(AsiaGameHub) -   ENJOY, a leading iGaming content developer, has received official certification to supply its products in the Italian market, marking a major milestone in the company’s European expansion strategy. After securing approval from Italy’s regulatory authority, Agenzia delle Dogane e dei Monopoli (ADM), ENJOY is now authorized to offer its full portfolio of slot titles, live casino offerings and hybrid live experiences to licensed operators across one of Europe’s most established and competitive iGaming jurisdictions. This certification represents a critical step in ENJOY’s long-term growth plans, allowing the company to enter the Italian market through a series of upcoming partnerships with leading local operators. These integrations will introduce Italian players to ENJOY’s unique mix of engaging game mechanics and high-quality production. The provider’s portfolio includes a range of top-performing slot titles built around proven game mechanics such as Bison Strike and recent launches like Hotfire Diamonds XXL. It also features a growing suite of live game show experiences including Enchanted Forest and the upcoming Energy Roulette Hold & Win, produced at its state-of-the-art studio. Italy’s mature regulatory framework and highly competitive landscape make it a strategically important market for suppliers looking to build a strong European presence, aligning closely with ENJOY’s focus on regulated growth and sustainable market entry. Christos Zoulianitis, Chief Commercial Officer at ENJOY, stated: “Securing certification for the Italian market is a key milestone in ENJOY’s European expansion. Italy is one of the most established and competitive regulated markets, and gaining approval to supply our content here reflects both the quality of our portfolio and our commitment to meeting the highest regulatory standards. “This certification allows us to move forward with a number of exciting operator partnerships, ensuring our games are introduced to Italian players in a way that supports long-term growth and strong player engagement.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

Peter & Sons Expands into the German Market via Partnership with Staatliche Toto-Lotto GmbH Baden-Württemberg

(AsiaGameHub) -   Peter & Sons, an innovative iGaming studio based in Barcelona, has expanded its European presence by entering into a new partnership with erwin, the virtual slots platform of Staatliche Toto-Lotto GmbH Baden-Württemberg, a highly respected and established gaming operator in Germany. Established in 1948, Staatliche Toto-Lotto GmbH Baden-Württemberg has developed a solid reputation for reliability, trust, and innovation in Germany's regulated gaming industry. The company is a key player in the nation's lottery system and continues to broaden its digital entertainment portfolio through licensed online gaming products. Since 2023,Staatliche Toto-Lotto GmbH Baden-Württemberg has offered virtual slot games at www.lotto-bw.de/erwin, where a wide variety of entertaining and attractive slots are available and regularly updated. Additionally, Staatliche Toto-Lotto GmbH Baden-Württemberg seeks to provide gambling products that meet the changing demands of its customers. The organization places a strong emphasis on integrity and security, making adherence to youth and player protection regulations a primary concern. Known for its collection of art-focused games, unique characters, and captivating game environments, Peter & Sons has gained worldwide acclaim for advancing creative limits in slot development. This collaboration will enable German players to enjoy a handpicked assortment of the studio's top releases, furthering Peter & Sons' expansion in regulated European markets. Yann Bautista, Founder and Commercial Director at Peter & Sons, said: "We are thrilled to collaborate with Lotto Baden-Württemberg, an operator that has built substantial trust among German gaming enthusiasts. Germany is a significant regulated market for our company, and partnering with such a reputable organization enables us to present our games to a wide audience that values premium entertainment and unique design." Barbie Nerz, Head of Online Games at Staatliche Toto-Lotto GmbH Baden-Württemberg: "Peter & Sons has established a reputation for creating visually impressive and highly captivating games, and we are pleased to integrate their portfolio into our platform. Our objective is consistently to deliver varied, premium content to players, and this alliance marks further progress in enhancing the entertainment options we provide." This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

EGT Digital to Display Key Innovations at BiS SiGMA Americas 2026

(AsiaGameHub) -   EGT Digital is set to take part in BiS SiGMA Americas 2026, which will run 6–9 April in São Paulo, Brazil, where attendees can connect with the company's team at stand L146. Fresh off its recent appearance at SBC Summit Rio, the firm continues to deepen its engagement in the Brazilian market, bringing a curated showcase of high-performing content and cutting-edge technology solutions. One of the event's key highlights will be Panda Ventura, one of EGT Digital’s most well-received recent launches. Pairing a unique visual identity with smooth, intuitive gameplay, this title offers a well-balanced flow that builds excitement naturally and encourages longer play sessions. As the first entry in the new Ventura series, it lays the foundation for a character-driven lineup that will soon expand to include Tiger Ventura. Alongside this title, attendees will get to explore a full portfolio of 180+ in-house slot titles, including the proven jackpot series Bell Link, Clover Chance, and Gods & Kings Link, all engineered to drive strong user engagement and consistent performance across global markets. EGT Digital will also present X-Nave, its modular iGaming platform that integrates Casino, Sportsbook, CRM, Payment Gateway, Bonus Hub, and a powerful Aggregator with 20,000+ games from 200+ providers. The platform features a high-performance Sportsbook that delivers flexible integration, advanced personalization, and a fast, seamless betting experience, while the company's proprietary AI boosts engagement through intelligent promotional tools and automated functionalities. Its participation in BiS SiGMA Americas underscores EGT Digital’s ongoing commitment to LATAM and Brazil, where it supports operators with scalable, high-performance solutions customized to meet local market needs. Attendees visiting booth L146 will also have the chance to view and test EGT’s VLT products, which were developed specifically for the Brazilian market. Following their successful debut at SBC Summit Rio earlier in March, the Video Lottery Terminals Super Sorte 27/27 ST and Super Sorte 43V, along with the online betting terminals Top Estrela and Bar Estrela, are expected to draw significant interest at SiGMA Americas. These terminals stand out for their modern design, user-friendly features, and engaging gaming experience. In addition, the popular multigame package GOLD VLT will also unveil its collection of 50 captivating titles, created for the local gaming audiences. With an expanding portfolio and a technology ecosystem built for performance and adaptability, EGT Digital continues to deliver solutions truly Designed to Perform. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

The Official Megaways Casino is Back — ‘Play the Mega Way’

(AsiaGameHub) -   SkillOnNet has brought back the official Megaways Casino by relaunching MegawaysCasino.com. The platform re-establishes itself as the ultimate destination for the Megaways mechanic, featuring a new design, updated branding, and a commitment to its core message: 'Play the Mega Way.' Since its 2016 debut, Megaways transformed the online gaming landscape. The dedicated casino now returns as a dynamic, entertainment-focused platform tailored for today's players. The casino debuts with an extensive collection of Megaways games, featuring titles such as Monopoly Megaways, Rasputin Megaways, Extra Chilli Megaways, and Bonanza—the pioneering game that first showcased the Megaways concept. Beyond its comprehensive Megaways selection, the site offers more than 8,000 games spanning premium slots, crash games, table games, and live casino options, providing extensive variety. Created by Big Time Gaming, Megaways revolutionized slot design through its dynamic reel-modifier system that provides up to 117,649 winning combinations per spin. This breakthrough fundamentally altered the online gaming industry's trajectory and emerged as one of the most iconic and broadly licensed mechanics in contemporary iGaming. Megaways Casino now stands as the sole official online casino brand completely committed to honoring this heritage. As part of SkillOnNet's portfolio, the brand makes its comeback with a contemporary, performance-driven platform, proprietary content, striking visual branding, and a sustained focus on the UK market. Giordana Anticoli Kalifa, Country Manager Emerging Markets at SkillOnNet, commented: "Play the Mega Way" represents more than just a slogan. It embodies the essence of Megaways—the intense pace, exciting diversity, and inherent unpredictability of the mechanic—and infuses it throughout the entire brand experience.Megaways has consistently ranked among the most influential and recognizable mechanics in online gaming. Through this relaunch, we're not merely reviving a brand; we're constructing a complete entertainment ecosystem centered around it. "'Play the Mega Way' captures our goal of converting the dynamic energy, massive scale, and unpredictable essence of the Megaways mechanic into a comprehensive brand experience. We cater to players who demand more." This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

中國抗體(03681.HK)2025年度虧損同比下降約43.3% 管線開發取得重大進展

香港, 2026年3月24日 - (亞太商訊 via SeaPRwire.com) - 中國抗體製藥有限公司(「中國抗體」或「公司」,連同旗下附屬公司統稱「集團」,股份代號:03681.HK)欣然公布截至2025年12月31日止年度(「年內」)的全年業績。年內,公司虧損由截至2024年12月31日止年度的人民幣1.85億元减少人民幣0.80億元至約人民幣1.05億元,主要得益于公司聚焦SM17 1b期臨床、劑型橋接研究及2期臨床籌備,研發成本較2024年大規模臨床研究有所下降。截至2025年12月31日,公司可動用資金總額約人民幣3.52億元,較上年同期的人民幣1.41億元顯著增長。年內,集團獲得睿遠、富國、易方達等多家知名機構投資者支持,公司完成兩輪股份配售,合計募集所得款項淨額約4.93億港元,帶動融資活動所得現金流淨額達人民幣3.29億元,爲後續研發及臨床推進提供了充足資金支持。核心産品SM17取得多項突破性進展SM17是全球首創(First-in-Class)的靶向IL-25受體的人源化單抗,通過靶向II型免疫核心「警戒素(Alarmin)」分子白細胞介素25(IL-25)受體,調節II型炎症反應。SM17具有治療特應性皮炎(AD)、炎症性腸病(IBD)、哮喘、慢性鼻竇炎伴鼻息肉(CRSwNP)及特發性肺纖維化(IPF)的潜力。在特應性皮炎(AD)領域,SM17精准作用于II型免疫反應的上游,通過阻斷被稱作「警報素「的關鍵細胞因子IL-25,從源頭上抑制導致AD的炎症級聯反應。當前,已獲批上市的AD療法(包括生物製劑)雖然可以大大改善患者的濕疹面積和嚴重程度指數以及生活質量。然而目前在研在售藥物無法同時滿足快速起效止癢,皮損恢復,同時具備良好安全性的臨床需求,市場尚存在巨大空間。SM17的創新之處在于,它通過靶向Th2炎性細胞因子通路上游(如IL-25受體),從而對下游信號通路的致病因子産生抑制效果,且在臨床前研究中展現出快速止癢、顯著修復皮損以及良好安全性的潜力,直擊現有療法痛點。2025年4月,SM17在中國治療中重度特應性皮炎的1b期研究中,取得了令人鼓舞的積極結果:揭盲後的12周頂線數據顯示,高劑量組的91.7%的患者實現瘙癢緩解指標(NRS-4),75%達到皮損恢復(EASI75)指標,41.7%達到完全或近乎完全清除AD症狀指標(IGA 0/1)。該結果顯著優于IL4/IL-13類單抗藥物且安全性與耐受性顯著優于Janus激酶抑制劑(JAK抑制劑),這使得SM17有望成爲一款可同時實現快速止癢、皮膚損傷修復,且安全性表現優异的同類首創及同類最優療法。SM17的研究成果已在多家國際頂級期刊發表。預計最早在2026年年中進入AD的2期臨床試驗。此外,SM17持續拓展出多個新的適應症,于本年度第二季度,SM17的適應症拓展進一步取得突破性進展。2025年12月11日,SM17用于治療IBD的新藥研究申請(「IND」)已提交予中國國家藥品監督管理局(「中國國家藥監局」)藥品審評中心(「藥品審評中心」),幷已獲受理,且IND隨後于2026年2月獲批。此次IND的提交,代表著SM17治療範圍從AD拓展至IBD的重要里程碑,涵蓋克羅恩病(「CD」)及潰瘍性結腸炎(「UC」)等慢性、衰竭性疾病,這些疾病存在顯著未滿足的醫療需求。于2025年10月,首組健康受試者已在中國給藥途徑轉換之1期橋接臨床研究中給藥。截至2025年12月31日,合共三十名健康受試者已入組且對全部健康受試者之隨訪于2026年2月完成。該橋接研究預期于2026年第二季度前完成。該研究數據將用作支持IBD適應症的進展直接推進2期臨床開發。早期在研管線布局提供持續創新動力在早期在研管線方面,公司持續取得積極進展。2025年6月合作夥伴雲頂新耀公布了EVER001(中國抗體SN1011)用于治療原發性膜性腎病(PMN)的1b/2a期臨床試驗的積極結果,進一步提升了管線的商業化價值。同時,公司多項早期研發項目穩步推進。其中,抗CGC抗體是一款內部開發的全球首創人源化抗γc抗體。動物研究顯示,該抗體可能透過調節免疫細胞的擴增、自身反應性及組織浸潤,成爲治療白癜風、斑禿,甚至其他自身免疫性疾病的潜在治療藥物。目前正在針對該抗體進行CMC優化及毒理學研究,幷計劃最早在2026年第四季度前提交其治療斑禿的IND申請。雙特异性抗體候選藥物是一種新型雙特异性抗體,靶向核因子kappa-B配體受體激活因子(RANKL)及骨硬化蛋白,治療骨相關適應症。通過的內部體外及體內研究顯示,相較于市售批准的抗體(如地諾單抗及羅莫珠單抗),該候選藥物展現出更佳的療效。目前正在進行CMC優化,幷在非人靈長類動物中測試其毒性,幷計劃最早在2027年上半年前提交IND申請。協同推進戰略合作與BD授權,榮獲多項重磅榮譽公司于2025年8月與中山大學香港高等研究院有限公司(「SYSU-IAS」)簽訂全面戰略合作協議,本公司可直接使用SYSUIAS完備的實驗室設施與寶貴的數據資源,幷獲得包括靈長類及非靈長類實驗動物在內的科研資源支持,加速創新藥物研發進程,推動科研成果在全球範圍內向臨床應用轉化。同時公司正積極探索運用人工智能(AI)技術開展新靶點發現的可行性。2026年1月,公司受邀參加摩根大通醫療健康大會(JPM大會)幷與多家MNC、投資者分享了公司在自免領域的進展。依托雄厚的研發實力、豐富的管線儲備及精細化運營管理,公司于本年度榮獲多項重磅榮譽,包括粵港澳大灣區家族辦公室協會與香港國際家族辦公室協會聯合頒發的第二届「新質生産力企業大獎」,以及智通財經授予的「最具價值醫藥公司獎」。中國抗體董事長、執行董事兼首席執行官梁瑞安博士表示:「2025年,我們憑藉扎實的臨床數據證明了創新管線的全球競爭力,SM17在AD中的優异表現及其向IBD的拓展,標志著我們正從單一産品研發邁向平臺價值的持續兌現。展望2026年,生物醫藥行業正加速邁入『生物技術3.0時代』,創新驅動、多學科融合及全産業鏈智能化將成爲核心發展方向。我們將把握中國生物醫藥對外授權高速增長的歷史機遇,持續推進核心管線的臨床開發,深化國際合作布局。依托堅實的現金儲備、完善的産業鏈能力以及差异化創新優勢,爲股東創造長期價值,幷爲患者提供具有突破性的治療方案。」關于中國抗體製藥有限公司中國抗體製藥有限公司(股份代號:03681.HK)是首創新藥及潜在同類最佳抗體藥物研發領域的開拓者,專注于自身免疫性疾病、以及由此導致的神經系統疾病及其他難治的耗損性疾病,致力于解决未被滿足的醫療需求。中國抗體始終致力于開發針對全新靶點及通過創新機制的治療性抗體,旨在現有療法效果不佳的領域實現差异化臨床成果。其豐富的研發管線包括:SM17在AD治療中展現出卓越的止癢效果、皮膚清除率及安全性,同時在哮喘和特發性肺纖維化(IPF)領域具有應用潜力;其旗艦抗CD22舒西利單抗,除了臨床驗證對類風濕關節炎(RA)具有臨床療效外,目前正針對系統性紅斑狼瘡(SLE)和阿爾茨海默病開展臨床評估;另一款抗CGC(共同γ鏈)創新單抗,正準備進入治療斑禿和白癜風的臨床研究;中國抗體亦研發了一款能同時刺激骨胳生長及抑制骨胳流失、治療骨質疏鬆症的雙特异性抗體。中國抗體以突破性療效爲核心追求,不斷重新定義患者護理標準,穩居突破性療法領域的領軍地位。此新聞稿由真灼財經代中國抗體製藥有限公司發布投資者及媒體查詢聯絡人:Bunny LeeCitrus JiangWendy Huang電話:(852)5316 9995電郵:ir_sinomab@zhenzhuoglobal.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SinoMab (03681.HK) Achieves Approximately 43.3% Year-over-Year Decrease in Annual Losses for 2025, Marking Significant Progress in Pipeline Advancement

HONG KONG, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”; stock code: 03681.HK) is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”).During the year, loss for the year was approximately RMB105.0 million, decreased by RMB80.1 million from RMB185.1 million for the year ended 31 December 2024. The Company focused on SM17 Phase 1b clinical, transformation bridging study and preparation of Phase 2 clinical trial in 2025, of which the cost was less than large scale clinical studies in 2024. As at 31 December 2025, total funding available to use was approximately RMB351.5 million, representing a significant increase compared to RMB141.4 million as at 31 December 2024. During the year, the Group gained support from well-known institutional investors including Foresight, Fullgoal, and E Fund, completed two rounds of new share subscriptions under general mandate and successfully raised an aggregate amount of approximately HK$493.7 million in net proceeds. This drove net cash flows from financing activities for the Reporting Period to approximately RMB329.4 million, providing sufficient funding to support subsequent R&D and clinical advancement.SM17 Achieves Multiple BreakthroughsSM17 is a global first-in-class humanised monoclonal antibody (mAb) targeting the receptor for IL-25, which is capable of modulating Type II allergic reaction by targeting the receptor of a critical “alarmin” molecule interleukin-25 (IL-25). The compound has the potential for treating atopic dermatitis (AD), Inflammatory Bowel Disease (IBD), asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and idiopathic pulmonary fibrosis (IPF).In the field of atopic dermatitis (AD), SM17 precisely targets upstream drivers of Type 2 immune responses by blocking IL-25, a key “alarmin” cytokine, thereby suppressing the inflammatory cascade at its source. While currently approved AD therapies, including biologics, can significantly improve Eczema Area and Severity Index (EASI) scores and patients’ quality of life, current drugs under development or on the market cannot simultaneously meet the clinical needs for rapid itch relief, skin lesion recovery, and good safety profiles, indicating substantial unmet market demand. SM17’s key innovation lies in its upstream modulation of the Th2 inflammatory cytokine pathway via IL-25 receptor inhibition, thereby suppressing multiple downstream pathogenic signaling pathways. Preclinical studies have demonstrated its potential for rapid itch relief, significant skin lesion recovery, and a favorable safety profile, directly addressing the key limitations of current therapies.In April 2025, SM17 achieved encouraging positive results in a Phase 1b study in China for the treatment of moderate to severe atopic dermatitis (AD): 12-week topline data after unblinding showed that in the high dose group, 91.7% of patients achieved pruritus relief (NRS-4), 75% achieved skin healing (EASI 75), and 41.7% achieved clear or almost clear signs of AD (IGA0/1). These results significantly outperform IL-4/IL-13 monoclonal antibodies and demonstrate a significantly better safety and tolerability profile than Janus Kinase inhibitors (JAK inhibitors), making SM17 potentially the first-in-class and best-in-class therapeutics which can simultaneously achieve rapid onset of action on pruritic relief, skin healing with a good safety profile. Study results of SM17 were published in various leading international journals. Phase 2 clinical trial for AD is expected to be entered into as early as mid-2026.On 11 December 2025, an Investigational New Drug application (“IND”) for SM17 in the indication of IBD was filed with and accepted by the Center for Drug Evaluation (the “CDE”) of the National Medical Products Administration of China (“NMPA”), and the IND was subsequently approved in February 2026. This IND submission represents an important step toward expanding SM17’s therapeutic scope beyond AD to IBD, including Crohn’s disease (“CD”) and ulcerative colitis (“UC”), which are chronic, debilitating conditions with significant unmet medical needs. In October 2025, the first cohort of healthy subjects was dosed in a Phase 1 bridging clinical trial for the route of administration conversion in China. As of 31 December 2025, a total of 30 healthy subjects had been enrolled and our follow-up visits for all healthy subjects were completed in February 2026. This bridging study is expected to be completed by the second quarter of 2026. Data from this study will be leveraged to support the progression of the IBD indication directly to Phase 2 clinical development.Early-Stage Pipelines Drive Continuous Innovation GrowthIn terms of early-stage pipeline development, the Company continues to make steady progress. In June 2025, Its partner, Everest Medicines, has announced positive results from the Phase Ib/IIa clinical trial of EVER001 (SinoMab’s SN1011) for the treatment of primary membranous nephropathy (PMN), further enhancing the commercial value of the pipeline.At the same time, multiple early-stage R&D programs are progressing steadily. Anti-CGC antibody is an in-house developed, first-in-class humanised anti-γc antibody. Our in vitro assays suggested that our antibody could suppress inflammation and autoimmunity driven B, T and NK cell activation. Animal studies demonstrated that our antibody could be a potential therapeutic agent for the treatment of vitiligo, alopecia areata and possibly other autoimmune diseases through the modulation of immune cell expansion, autoreactivity and tissue infiltration. We are currently in the process of CMC optimisation and toxicology studies for our antibody and plan to submit our IND application for the treatment of alopecia areata by the fourth quarter of 2026 at the earliest.Bispecific antibody candidate is a novel, bispecific antibody targeting Receptor activator of the nuclear factor kappa-B ligand (RANKL) and sclerostin for bone-related indications. bsAb processes differential mechanisms of action tailored for the treatment of osteoporosis. Our in-house in vitro and in vivo studies demonstrated our candidate to have enhanced efficacy over market-approved antibodies such as Denosumab and Romosozumab. We are currently in the process of optimising CMC and testing toxicity in non-human primates and plan to submit our IND application by the first half of 2027 at the earliest.Expanding Strategic Partnerships and Gaining Strong Industry RecognitionsIn August 2025, the Company entered into a comprehensive strategic cooperation agreement with Sun Yat-sen University Institute of Advanced Studies Hong Kong Limited (“SYSU-IAS”). Under the cooperation agreement, the Company enjoys direct access to SYSU-IAS’s comprehensive laboratory facilities and valuable data resources, as well as access to primate and non-primate animal studies supply resources, to accelerate the development of innovative drugs and promote the translation of scientific research into clinical applications worldwide. Furthermore, the Company is actively exploring the feasibility of using artificial intelligence (AI) technology for new target identification.In January 2026, the Company was invited to participate in the J.P. Morgan Healthcare Conference, where it shared its progress in the autoimmune field with multiple multinational pharmaceutical companies (MNCs) and investors.With the support of our strong R&D capabilities, extensive pipeline assets and refined operational management, we are thrilled to obtain renowned awards during the year, including the 2nd “New Quality Productive Forces Enterprise Award” jointly presented by the Greater Bay Area Family Office Association and the Hong Kong International Family Office Association, as well as the “Most Valuable Pharmaceutical Company Award” presented by Zhitong Finance.Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of SinoMab, comments: "In 2025, we demonstrated the global competitiveness of our innovative pipeline with solid clinical data. The outstanding performance of SM17 in AD and its indication expansion to IBD signify our continuous transition from single-product R&D to the realisation of platform value. Looking ahead to 2026, the biopharmaceutical industry has been accelerating into the “Biotech 3.0 Era”, which is characterised by innovation-driven development, multidisciplinary integration, and intelligent processes across the entire supply chain. We are well-positioned to capture the historic opportunity of the rapid growth of out-licensing deals in China’s biopharmaceutical industry, continue to advance the clinical development of our core pipelines, and deepen our international partnership footprint. Relying on our solid cash reserves, full-spectrum capabilities across the industry chain and the principle of differentiated innovation, we strive to maximize the returns of shareholders in the long run and provide life-changing breakthrough therapies for patients.”About SinoMab BioScience LimitedSinoMab BioScience Limited (Stock Code: 03681.HK) is a pioneer in the research and development of first-in-class and potential best-in-class therapeutic antibody drugs, focusing on autoimmune diseases, neurodegenerative disorders, and other debilitating diseases, committed to addressing unmet medical needs. SinoMab has consistently focused on developing therapeutic antibodies targeting novel targets and employing innovative mechanisms, aiming to achieve differentiated clinical outcomes in areas where existing therapies have shown limited efficacy. Its rich R&D pipeline includes: SM17, which has demonstrated exceptional anti-pruritic effects, skin clearance rates, and safety profiles in the treatment of AD, with potential applications in asthma and idiopathic pulmonary fibrosis (IPF); its flagship anti-CD22 antibody, Suciraslimab , which has been clinically validated for efficacy in rheumatoid arthritis (RA) and is currently undergoing clinical evaluation for systemic lupus erythematosus (SLE) and Alzheimer's disease; another innovative anti-CGC (common gamma chain) monoclonal antibody, which is preparing to enter clinical studies for the treatment of alopecia areata and vitiligo; and a bispecific monoclonal antibody developed by SinoMab that simultaneously stimulates bone growth and inhibits bone loss for the treatment of osteoporosis. With breakthrough efficacy as its core pursuit, SinoMab continuously redefines patient care standards and maintains a leading position in the field of breakthrough therapies. This press release is issued by Zhenzhuo Group on behalf of SinoMab BioScience Limited.Investor and Media InquiriesContact Person: Bunny LeeCitrus JiangWendy HuangPhone: (852) 5316 9995Email: ir_sinomab@zhenzhuoglobal.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

將近五分之三的美國人認為,AI將使擁有房屋所有權更加遙不可及

(SeaPRwire) -   美國房市與戰後時期已大相徑庭。當時,房屋中位價約為7,300美元,若經通膨調整,約為101,000美元。Z世代和千禧世代尤其難以實現被視為美國夢核心的購屋目標。去年,首次購屋者的中位年齡為40歲,比十年前的30歲出頭有所上升。而現在,潛在購屋者正受到一個競爭現實的衝擊:一場日益逼近的AI驅動「失業末日」,這可能會讓購屋變得更加遙不可及,甚至完全抹去購屋的可能性。 「我認為AI及其潛在的AI裁員是造成經濟焦慮的主要原因,這種焦慮阻礙人們承諾購屋——儘管購屋變得更負擔得起,」Redfin首席經濟學家Daryl Fairweather告訴。 由Ipsos進行並由房地產經紀公司Redfin委託的一項針對4,000名美國居民的新調查發現,近五分之三的美國人(59%)認為AI將會淘汰工作,並使購屋變得更加困難。美國人不僅要應對不斷上漲的房屋成本,現在還必須擔心因AI而失業——這使得實現美國夢的目標變得更加遙遠。 Z世代的情況已變得嚴峻——事實上,許多年輕成年人的父母已介入協助支付頭期款。由於老一輩在今日美國掌握絕大多數財富,我們看到「財富大轉移」的一種方式是父母協助支付住房成本,甚至將購屋置於大學學費之上,將其視為世代財富中更具可轉移性和實質性的組成部分。 AI對房市的影響 Fairweather表示,對AI的負面態度實際上可能導致房市觀望。儘管過去幾年抵押貸款利率一直居高不下,她說最近利率的下降本應導致購屋量增加。但事實並非如此,她將此歸因於AI恐懼所驅動的經濟焦慮。 「人們非常擔心他們會因為[AI]而吃虧,」她說。「我認為這可以追溯到其他技術進步是如何處理的,以及過去那些高薪中產階級工作是如何被自動化取代的。」 這種情緒在不同政治意識形態中是一致的。約63%的民主黨人和57%的共和黨人同意,AI的進步將會淘汰工作,並使購屋變得更加困難。 儘管如此,許多美國人認為AI將產生截然相反的效果。30%的受訪者表示,AI的進步將有助於提振美國經濟,進而幫助更多人負擔得起房屋。 儘管越來越多的商界領袖讚揚AI的生產力潛力,但實際情況尚未反映出大規模裁員的預測。今年到目前為止,Jack Dorsey的Block和澳美公司Atlassian等科技公司已將大規模裁員歸因於AI。但上個月發表的一項研究顯示,數千名公司高管尚未看到AI對就業或生產力產生實際影響。 「這些恐懼部分可能被誇大了,因為所有關於AI將如何變革的言論,」Fairweather說。「但那可能只是炒作。」本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

新冠病毒如何讓美國與科學為敵 — 以及需要什麼才能贏回科學

(SeaPRwire) -   人類史上最偉大的科學成就之一,幾乎在一夜之間淪為政治負債。當Covid-19大流行爆發時,科學家在短短一年內就鑑定出病毒、破解其秘密、研發出疫苗、投入量產,並讓這種疾病變得可控制——從未有哪個文明能進展得這麼快。 而人們的回應是什麼?川普政府嘲諷個別科學家、刪減經費、開除專家、關閉相關單位。這幾乎就像我們對二戰勝利歸國的美軍開槍一樣。為什麼勝利會淪為一場文化戰爭?我們又能怎麼解決這個問題? 科學首先在哪裡出錯 先從科學界哪裡出錯說起:首先是CDC的檢測爛攤子。該機構缺乏監督大流行所需大規模檢測的能力。更糟糕的是,它的檢測技術因為製造瑕疵出了大包,而這機構——以典型的官僚作風——不向私營業界求助。FDA更拒絕核准那個失效檢測的替代方案,讓情況雪上加霜。沒有檢測,政策制定者就無法追蹤疫情;他們根本是盲目行動。第一個教訓:解決方案:CDC應該退出大流行檢測試劑生產的業務,並在新傳染病出現時,與美國生物製藥公司更緊密合作開發診斷工具。 第二,科學家從來沒能解釋為什麼他們的指引不斷改變——這滋養了大眾的懷疑。答案很簡單:他們當下也還在認識這個病毒。關於戴口罩的建議不斷變動引發憤怒,因為不論是政府、媒體還是大眾,鮮少有人理解這種變動從何而來。Tony Fauci並不是隨便玩弄全國人民而已。 一開始研究人員假設COVID的傳播特性和流感類似。接著他們發現COVID會透過無症狀感染者傳播——這個關鍵差異使得新指引彷彿憑空出現。Fauci並沒有閃爍其詞;科學本來就是即時演進的。教訓是:科學家必須在認知改變時帶著大眾一起理解,而不是只公布新結論。 白宮不為人知的故事 對科學的攻擊有一段鮮少被完整說出的政治歷史。這一切始於白宮對大流行缺乏準備。國家安全委員會已經解散了專責處理生物威脅的小組,而情報界花了一個多月才把Covid列入總統每日情報簡報,就算列入之後也被他們擱在一邊不理。 一切在三月第一週改變。紐約市變成死亡禁區。據報導,Donald Trump總統看到皇后區艾姆赫斯特醫院停屍間外停滿冷凍卡車的畫面大受震驚,那裡離他生長的地方不遠。股市重挫。NCAA取消了March Madness。商家停業、學校關閉。Dr. Deborah Birx接任白宮Covid協調員,建立了一個模型,精確預測了難以想像的死亡人數:未來兩個月將有10萬到24萬人死亡。 在那樣的背景下,Donald Trump在經歷否認和模棱兩可之後,做出了合理的回應。不在鏡頭前也不上Twitter的時候,他做出了艱難的決定。他聽從健康顧問的意見,衡量他們的建議和經濟學家提出的挑戰,關閉邊境、支持封鎖,而且——最引人注目的是——拋開正常程序,整合科學、物流和大筆資金,以所謂的曲率速度研發疫苗。 政治如何汙染了這灘池水 但到了四月,封鎖已經開始造成損害,總統大選逐漸升溫,川普不斷聽到他商界友人的不滿。由時任經濟顧問委員會主席Kevin Hassett率領的經濟團隊,編造出新的、更樂觀的預測,指到Memorial Day為止,Covid死亡人數只會有2萬6000人——但這個模型公布時,已經有比這個數字更多的人死亡了。這個新估計讓川普對他的醫療團隊滿腹懷疑。 當科學領袖不斷反對川普推崇的羥氯喹、伊維菌素和康復者血漿,懷疑就轉變成憤怒。他公開和他們翻臉——將FDA、CDC和NIH抹黑成致力於推翻他的深層政府陰謀集團。 四月中旬,憤怒演變成公開對抗。川普公開支持那些持槍、揮舞川普旗、譴責封鎖的小型抗爭群眾。他的推文擴大了這場「解放」美國的鬥爭——從Covid限制,以及他的敵人手中解放:那些傲慢的菁英——科學家、官僚、民主黨人——推出這些限制,只為了展現專家越權。 然而,川普發了一條太過火的推文,他抨擊FDA的Covid疫苗試驗進展太慢,稱那「只不過是另一場政治暗殺」。這逼得九家製藥公司買下報紙廣告,承諾在證明疫苗安全有效之前不會推出任何疫苗。為了證明疫苗的安全性,FDA將臨床試驗延長數週,使得FDA核准疫苗的時間落在選舉日之後——也讓FDA永遠纏上MAGA宣傳的「選舉被動手腳」的論述。 反疫苗先鋒 川普在選後一場造勢活動提到自己已經施打COVID疫苗,現場卻出現噓聲,此舉給了反科學風潮最後一推。他立刻轉向,加入了自己在無意間協助催生的反疫苗運動。不令人意外,如果川普二度上任,他將任命Robert F Kennedy, Jr.——還有DOGE——在衛生與科學領域「隨意整頓」。反對疫苗和公共衛生的風潮迅速席捲保守派陣營。美國有26個州針對行之有年的公共衛生主管機關頒布新的嚴格限制,這些單位經過多年預算緊縮早就已經被掏空。 但科學事實是頑強的。一如歷史學家Richard Hofstadter曾經寫到,反專家傳統在美國歷史中是起起落落的浪潮。上升的麻疹感染率——以及期中選舉將近,承擔公共衛生危機的政治代價——似乎已經讓情勢開始扭轉。Kennedy和他的盟友已經開始對疫苗懷疑論立場軟化。 接下來該怎麼走 前行的道路雖然需要政策改革,不過不止於此,儘管政策改革確實重要。科學家需要即時傳播演進中的知識。政治人物需要拒絕將不確定性武器化。各機關需要足夠的資金和彈性來大規模回應疫情。 但最終,保護社會需要更深層的東西:一個能夠團結、彼此關懷、跨越分歧、關心鄰居健康與安全的國家。除非我們學會引導亞伯拉罕·林肯所說的「人性中良善的天使」,否則我們永遠無法好好對抗大流行。沒有這一點,我們也無法擊退下一個傳染性威脅。 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

HIES introduces plant-based lubricant that reduces air compressor lifecycle CO(2) emissions by 40%

TOKYO, Mar 24, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Industrial Equipment Systems Co., Ltd. (hereinafter HIES, part of Hitachi, Ltd. Connective Industries (CI) Sector) has launched “GREEN SCREW OIL”, a plantbased lubricant for oil-flooded screw air compressors. Because the plant-derived raw materials absorb CO₂ during growth, the new lubricant cuts manufacturing-stage CO₂ emissions by approximately 90%. Even including emissions at disposal, its CO2 emissions across the entire lifecycle can be reduced by approximately 40%(estimated value) compared to conventional synthetic oils.Air compressors are widely used manufacturing and social infrastructure fields. HIES' air compressors form a significant part of the installed base for “HMAXTM(*1) Industry”, a digital service that embodies Lumada 3.0(*2), offering predictive diagnostics powered by machine learning and operational/maintenance support through generative AI. Delivered via “FitLiveTM(*3)”. These solutions support efficient and sustainable operations. Aligned with Hitachi’s sustainability strategy “PLEDGES(*4)”, which is based on the management plan “Inspire 2027,” and promotes decarbonization under the P: Planet pledge, “GREEN SCREW OIL” further enhances the environmental value of digitalized assets and supports the creation of more sustainable industrial sites.Product OverviewOil-flooded screw air compressors require lubricants to prevent component wear and provide cooling, as a pair of screw rotors rotate at high speeds to compress air. Conventional lubricants are derived from crude oil, and CO2 is emitted during their manufacturing process. “GREEN SCREW OIL” uses plants as raw materials that absorb CO2 through photosynthesis. This means that during manufacturing, CO2 emissions are reduced by 90%. Even when considering the disposal stage, total emissions are reduced by 40%. Its performance is equivalent to conventional synthetic oils, and it can be used with a two-year replacement cycle.Going forward, we also plan to expand this initiative to Hitachi Global Air Power's oil-flooded screw air compressors, which are under Sullair brand within Hitachi Group, and HIES’ oil-free air compressors. Hitachi Group air compressors hold a significant global market share. We estimate that replacing all lubricant used in the Group's air compressors with plant-based alternatives could reduce CO2 emissions by over 2,000 tons annually.Hitachi’s Connective Industries (CI) Sector, to which HIES belongs, focuses on “Integrated Industry Automation”, which aims to expand “HMAX Industry” into growth industries horizontally. HMAX Industry provides next-generation solutions for the industrial field that combines data from an abundant installed base of products (digitalized assets), domain knowledge, and advanced AI. As part of the CI Sector, HIES aims to drive innovation for frontline workers through the delivery of “HMAX Industry” that embodies Lumada 3.0.(*1) Hitachi Group's next-generation solutions leveraging AI to innovate social infrastructure, deployed globally and across industries(*2) Lumada 3.0: An evolution of Lumada, leveraging AI enhanced with Hitachi's domain knowledge. Lumada is the collective term for Hitachi's advanced digital technologies—solutions, services, and technologies—designed to extract value from customer data and accelerate digital innovation.(*3) FitLive® Introduction Page (Hitachi Industrial Equipment Corporate Site, Japanese only)(*4) Hitachi Ltd. press release (June 27, 2025) “Hitachi's new sustainability strategy "PLEDGES"”About HIESHIES enhances productivity across various industries — including data centers, batteries, electronics and semiconductors and pharmaceuticals — through high-efficiency products such as compressed air systems, grid edge solutions, drives and coding and marking equipment. Our innovative solutions and services integrate digital technology to drive customer success and contribute to a more sustainable society. We support customers throughout the entire product lifecycle, from maintenance to recycling. For more information on Hitachi Industrial Equipment Systems, please visit https://www.hitachi-ies.com/Business ContactHitachi Industrial Equipment SystemsGlobal Air Power Group Marketing & SalesManagement DivisionMarketing & Strategic Planning Dept.HIES-MSM-marketing@hitachi-ies.co.jp Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

NagaCorp Reports $309.9 Million Profit for 2025 in Cambodia

(AsiaGameHub) -   NagaCorp saw a significant increase in its 2025 earnings, driven by improved revenue and EBITDA across various sectors at its NagaWorld complex in Phnom Penh. The growth was fueled by robust mass-market results, increased VIP engagement, and the introduction of gaming products with better margins. Good to Know NagaCorp's net earnings for 2025 totaled $309.9 million. Total revenue for the group increased by 26.2% to approximately $709.7 million. The introduction of side bets and an improved win rate contributed roughly $39 million in additional income. NagaWorld Boosts NagaCorp’s Financial Performance The company reported that its annual net profit climbed to $309.9 million, a substantial rise from the $109.6 million recorded the previous year. The 2024 figures had been impacted by a $89.1 million non-cash impairment charge related to a resort development in Vladivostok, Russia. For 2025, revenue reached nearly $709.7 million, representing a 26.2% increase, while EBITDA surged to $404.4 million from $202.8 million in 2024. This led to an EBITDA margin of 57.0% and a net profit margin of 43.7%. Management attributed these improvements to increased business volumes and a strategic emphasis on the mass market. They also highlighted the success of high-margin offerings like side bet games, which enhanced the gaming experience and boosted overall profitability.Gross gaming revenue (GGR) at NagaWorld grew by 27.4% year-on-year to $691.6 million. Revenue from mass-market tables rose 27.2% to $342.4 million, while electronic gaming machines in the mass segment saw a 13.5% increase to $142.6 million. The company noted that mass-market success was supported by a 12.6% rise in business volume and a win rate of 22.9%. The implementation of side bet games helped elevate win rates throughout the year, contributing an estimated $39 million in extra revenue. The premium mass segment also played a key role, with high-spending visitors frequenting high-limit zones, improving table yields and shifting the customer demographic. Premium mass revenue now represents 38.5% of the total mass-market table GGR, up from 33.9% in the prior year. The VIP sector showed growth as well. Revenue from house-managed "premium VIP" services increased by 32.1% to $136.2 million, with rolling volume jumping 51.6% to $5.50 billion. This recovery was linked to an influx of high-value business travelers to Cambodia and increased spending by top-tier VIP clients.Referral VIP revenue climbed 57.2% to $70.4 million, supported by a 17.2% increase in rolling volume to $2.32 billion. NagaCorp announced an interim dividend of $0.0109 per share, totaling $48.3 million, scheduled for payment on August 7. This represents a 30% payout ratio based on earnings from the latter half of 2025. Management stated the dividend underscores their commitment to growth and shareholder returns. Despite the termination of a funding agreement for the Naga 3 expansion in December, the company remains committed to the project. Previous updates suggested that the project's scope and budget might be adjusted. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

Taiwan Shuts Down Cross‑Border Gambling Ring Tied to $1.03 Billion

(AsiaGameHub) -   Taiwanese law enforcement officials announced they dismantled a cross-border money laundering operation connected to illicit online gambling. The authorities estimate that the criminal organization transferred approximately TWD33 billion, equivalent to roughly US$1.03 billion, via transactions at Macau casinos. Good to Know Taiwanese officials stated the case encompassed approximately TWD33 billion in alleged illegal funds. Law enforcement reported that the scheme utilized 85 credit cards and culminated in 20 apprehensions. Investigators characterized the case as unprecedented for Taiwanese police. Taiwan Connects Macau Casino Chip Acquisitions to Online Gambling Proceeds The investigation commenced in the latter half of 2025, when Taiwan's Criminal Investigation Bureau tracked questionable money movements from numerous bank accounts associated with online gambling and fraudulent activities. The bureau indicated that funds were transferred into accounts controlled by certain individuals and subsequently applied to credit card balances. Investigators revealed that the organization enlisted third-party intermediaries in Taiwan to function as card-processing operatives. Surplus payments were purportedly placed into these accounts, thereby increasing their credit ceilings. Subsequently, the agents allegedly employed the cards to purchase substantial quantities of casino chips at Macau gaming establishments, redeem the chips for cash, and exchange the money into Hong Kong currency. Officials noted that the arrangement additionally enabled participants to take advantage of international credit card expenditure rewards. Essentially, the network stands accused of employing casino chip acquisitions as a mechanism for transferring and laundering gambling profits across national boundaries. Authorities reported that the alleged sum laundered abroad totaled approximately TWD33 billion. According to local media accounts referencing a police briefing on Monday, the operation involved 85 credit cards and led to the detention of 20 individuals, among them two alleged masterminds.The bureau declined to specify the duration of the purported scheme's operation. Nevertheless, investigators deemed it the inaugural case of this nature discovered by Taiwanese authorities. Items confiscated during the operation comprised approximately TWD230.95 million held in bank accounts, roughly TWD2.62 million in physical currency, along with currency-counting devices, cellular telephones, and credit cards. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

Pagcor Greenlights GLI for iGaming Testing in Philippines

(AsiaGameHub) -   Pagcor has designated Gaming Laboratories International LLC as the first independent testing laboratory for iGaming in the Philippines. This approval comes as the regulator intensifies oversight of the rapidly growing online gaming market. Good to Know GLI is the first company to gain accreditation under Pagcor’s new system. B2B iGaming suppliers in the Philippines are now required to hold accreditation. GLI will employ its GLI-19 standard to test platform fairness, security, and integrity. GLI Earns First Accreditation Under Pagcor’s New Rules GLI stated that this accreditation allows it to test and certify iGaming platforms in the Philippines. Under the new framework, all B2B suppliers must meet stricter regulatory and technical standards. The company noted it will apply “GLI-19: Standards for Interactive Gaming Systems” when evaluating submissions. According to GLI, this standard is already utilized in multiple jurisdictions. Pagcor Chairman and Chief Executive Alejandro Tengco said regulated gaming markets “ensure a safer and more sustainable gaming industry for all to participate in”. He further added: “Pagcor now requires all iGaming B2B suppliers operating in the Philippines to be accredited to ensure they comply to the rigorous requirements needed to protect iGaming players.” GLI President and CEO James Maida expressed thanks to Pagcor “for the trust” it continues to place in GLI. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.

同仁堂醫養(02667.HK)基石鎖定逾46% “百年中醫第一股”認購進入最後倒計時

香港, 2026年3月24日 - (亞太商訊 via SeaPRwire.com) - 這家承載356年品牌傳承的中醫醫療服務龍頭近日正在港股招股,背靠"老字號",補齊了同仁堂集團"制藥-零售-醫養"大健康生態圈的最後一塊拼圖 。本次全球發售1.08億股,其中香港公開發售約10%,國際發售約90%。基石投資者已鎖定占發行規模逾46%,基石占比接近最高限額。機構真金白銀入場:基石比例高,機構參與熱度足數據是最誠實的信號。據招股書披露,基石投資者航空港科技資本(香港)及Aurora SF將按發售價認購總金額約3.89億港元的股份,占全球發售規模逾46%,這一比例在近期港股IPO中處於較高水平。基石鎖定比例高意味著上市後可流通籌碼有限,對二級市場價格支撐更強。此外,基石鎖定期超過傳統規定的6個月,進一步增強了市場的預期。獲客成本極低:僅為同行業的六十分之一在醫療服務行業,獲客成本是決定盈利天花板的關鍵變量。同仁堂醫養背靠始創於1669年的"同仁堂"金字招牌,品牌壁壘的經濟價值可以用一個數字概括:2024年推廣費占收入比例僅約0.2%。然而就診人次卻從2022年的132.1萬飆升至2024年的297.7萬,CAGR高達50.1%。2025年前9月達253.6萬,同比再增21.5%。會員從43.6萬增至76.7萬(2025年9月),複購粘性強勁。隨著收入規模擴大,同行需要花在營銷上的每一分錢,對同仁堂醫養而言幾乎都可以直接轉化為利潤。這是任何競爭對手都無法在短期內複制的護城河。盈利拐點已確立:經調整淨利潤增長29%對於處於上市窗口的成長型企業,投資者最關心的是:盈利趨勢是向上還是向下?答案很明確——向上,且加速。財務數據顯示,公司已展現出穩健的盈利能力。2022年至2024年,公司已由虧損923萬元轉為盈利4620萬元,經調整淨利潤達6173萬元,增長達到29%;毛利同期從1.43億元增至2.22億元,年複合增長率為 24.8%;2024年現金轉化率87.2%,有息債務占比僅11.56%,持有現金2.25億元,盈利質量顯著提升 。同仁堂醫養當前的發展階段與固生堂上市時高度相似,盈利能力剛進入釋放通道,增長最快的階段可能尚未到來。複制增長階段:計劃新增20家醫療機構中醫醫療服務是業績基本盤,公司已構建包含25家醫療機構的分級診療網絡,其中自有醫療機構12家,管理醫療機構12家,此外還有1家互聯網醫院提供線上診療服務。截至2024年就診人數約300萬人,CAGR高達50.12%;2025年前9月約253.6萬,同比再增21.5%;會員數量約74萬人,合作藥店約500餘家。作為同仁堂集團打開增長空間的核心業務,醫療服務板塊規模還需要更強力的支持與擴張。根據其募集資金使用披露,該公司計劃新收購5家醫療機構、以輕資產的方式新建5家醫療機構,並額外向5-10家醫療機構提供管理服務。可見,其未來快速擴張的戰略清晰,"收購+輕資產新建+管理輸出"三路徑協同。非"名醫驅動":依靠標准化"體系驅動"對中醫醫療服務企業而言,最大的成長瓶頸在於"名醫能否複制"。同仁堂醫養正在用一套體系化的方法論回答這個問題。公司向上遊延伸,自建了供應鏈體系,完成了端到端的產業鏈閉環。除藥品外,健康產品銷售也實現了品牌價值的商業化變現。公司已獲授權在浙江省獨家銷售同仁堂爆款安宮牛黃丸系列產品,截至最後實際可行日期,公司已向超過4000家機構客戶銷售健康產品及其他產品。此外,公司將雲數字化系統紮根進網絡內每一家醫療機構,通過實時數據分析及管理,用智能系統代替"院長",正在向"人機協作式"新型連鎖醫療管理方式過渡。讓增長不再完全依賴於個別名醫的"人治",而是依托可複制的運營體系、數字化中臺和人才培養機制,實現規模化、標准化擴張。AI+中醫:醫藥數據壁壘深厚作為同仁堂集團在中醫服務領域唯一戰略性布局的載體,同仁堂醫養正站在傳統中醫與人工智能交匯的曆史拐點上 。同仁堂集團近期積極推動AI技術在中醫藥領域的落地應用,已與小米聯合打造"AI智能中醫藥健康服務智能體",將傳統中醫智慧與現代AI技術深度融合,形成"咨詢—建議—服務—購藥"的服務閉環 。展望未來,萬億規模的中醫醫療服務市場正迎來龍頭整合的黃金窗口期。同仁堂醫養以多輪驅動的發展模式、穩健的財務基礎及AI技術的前瞻布局,不僅完成了老字號資本版圖的最後一塊"拼圖",更開啟了中醫服務與前沿科技深度融合的新紀元。隨著上市募集資金的到位,相信同仁堂醫養有望加速推進核心業務的全面AI轉型,在萬億級中醫醫療服務市場中持續鞏固龍頭地位,引領行業邁向智能化新時代。轉載自格隆匯 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Alumni channel $35 million for 5c(c)

(AsiaGameHub) -   Alumni of the prediction market platform Kalshi are securing as much as $35 million for a new venture fund dedicated to startups in the prediction market space. This initiative serves as a further indicator that investor attention is shifting from trading platforms themselves to the underlying infrastructure that powers event-driven markets. Good to Know 5c(c) Capital intends to back approximately 20 startups within the coming two years. The fund's focus is on firms involved in market making, index creation, and tools for prediction markets. Initial supporters already feature prominent figures connected to Kalshi, Polymarket, and leading crypto and fintech investment networks. New Fund Targets the Plumbing Behind Prediction Markets A new investment vehicle named 5c(c) Capital is forming to target one of online trading's most rapidly expanding areas. According to regulatory documents and sources close to the fundraising, the effort is spearheaded by two early Kalshi employees and aims to gather up to $35 million. Rather than investing directly in consumer prediction platforms, the fund is targeting the foundational layer below them. This encompasses market makers, pricing mechanisms, index offerings, liquidity solutions, and essential infrastructure for event-based trading. Put simply, 5c(c) Capital is evaluating the components that enable prediction markets to operate more efficiently, price more swiftly, and expand more seamlessly. This focus is significant as the sector has expanded far beyond a niche. Both the regulated platform Kalshi and the on-chain platform Polymarket have reported consistent monthly trading volumes in the tens of billions, attracting increased interest from traders, developers, and institutional investors. Consequently, venture funding is now flowing not just to the marketplaces but also to the supporting software, data services, and trading frameworks.As reported by ChainCatcher, Kalshi CEO Tarek Mansour and Polymarket CEO Shayne Coplan are among the initial investors committed to the fund. Backers associated with Andreessen Horowitz, Ribbit Capital, and Multicoin Capital are also participating. This combined support is notable for a market frequently divided between regulated and crypto-native segments. Publicly, relations between the sector's leading companies have sometimes appeared contentious. Coplan has previously referred to Kalshi as "a Polymarket copycat" in interviews, as the two vie for liquidity, market listings, and regulatory positioning. Despite this, capital from both sides is now aligning behind a common broader belief: for the prediction market category to continue its growth, it requires improved infrastructure. An individual involved in the fundraising, who spoke anonymously, succinctly captured this rationale. "What we’re seeing now is investors underwriting the rails and tools that make these markets possible, not just the flagship venues," the person said. For entrepreneurs developing prediction markets, event contracts, index products, trading APIs, liquidity systems, or market-making technology, this represents a crucial signal. Investor attention is no longer concentrated solely on the most prominent consumer brands. Investment is also beginning to move into the sector's foundational "picks-and-shovels" layer, where the quality of infrastructure, tools, and execution can determine the ultimate winners. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.